The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
Ozempic doesn't just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food ...
How Ozempic is being misused and worsening eating disorders - IN FOCUS: Olivia Petter talks to experts who say that people ...
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?
A new generation of weight loss drugs has helped some people lose significant amounts of weight and improve their health.